Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.
We will increase some of our prices on April 1, 2023. Be sure to complete your order before this time to take advantage of current prices. See the new prices and get more information or speak with our friendly support team.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected] Learn more

Limited Use Label License: Luciferase Limited Use Label License


For research use only. This product and/or its use falls within the
scope of the claims of U.S. Patent No. 5,670,356, and pending and
allowed claims of U.S. Patent Application Nos. 11/825,304,
11/786,785, 11/316,042, 10/943,508, 09/645,706 and their corresponding
foreign patent applications assigned to Promega Corporation, and the
scope of the claims of U.S. Patent Nos. 5,583,024, 5,674,713, and
5,700,673 assigned to the Regents of the University of California and
licensed exclusively for certain fields of use by Promega Corporation.

The terms of the limited use license conveyed with the purchase and/or
transfer of this product are as follows: Researchers may use this
product in their own research and they may transfer derivatives to
others for such research use provided that at the time of transfer a
copy of this limited use statement is given to the recipients and the
recipients agree to be bound by the conditions of this limited use
license. Researchers shall have no right to modify or otherwise
create variations of the nucleotide sequence of the luciferase gene of
this product except that Researchers may: (1) clone heterologous DNA
sequences at either or both ends of said luciferase gene so as to
create fused gene sequences provided that the coding sequence of the
resulting luciferase gene has no more than four deoxynucleotides
missing at the affected terminus when compared to the intact
luciferase gene sequence, and (2) insert and remove nucleic acid
sequences in furtherance of splicing research predicated on the
inactivation or reconstitution of the luminescent activity of the
encoded luciferase.

In addition, Researchers must do one of the following: (1) use
luminescent assay reagents purchased from Promega Corporation for all
determinations of luminescence activity resulting from the research
use of this product and its derivatives; or, (2) contact Promega to
obtain a license for the use of this product and its derivatives. No
other use or transfer of this product or its derivatives is authorized
without the express written consent of Promega including, without
limitation, Commercial Use. Commercial Use means any and all uses of
this product and derivatives by a party for monetary or other
consideration and may include, but is not limited to use in: (1)
product manufacture; and (2) to provide a service, information or
data; and/or resale of the product or its derivatives, whether or not
such product or derivatives are resold for use in research. With
respect to such Commercial Use, or any diagnostic, therapeutic or
prophylactic uses, please contact Promega for supply and licensing

By opening and using this product, the purchaser agrees to be bound by
the conditions of this limited use statement.